0303.KLSE ALPHA
- Market cap
- MYR 1.33B
- P/E
- 27.5x
- P/B
- 7.26x
- ROE
- 28.3%
- Dividend yield
- 3.65%
- Fundamental score
- 2.1/5
Ratios use the latest price and the fiscal year ending May 2026.
Is 0303.KLSE undervalued?
Graham number0303.KLSE trades 197.9% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
ALPHA fundamental analysis
9 of 22 checks passedROE 2/2
High return on equity (28.3%), above 20%.
ROA 1/1
Return on assets (21.0%) is above the industry median (5.1%).
Profit Consistency 2/2
Profitable for 5 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 0/1
Not enough positive earnings history to compare last year's growth with the 5-year average.
Earnings Growth vs Industry 0/1
Last year's EPS growth (-6.2%) is below the industry median (28.6%).
Revenue Growth 2/2
Revenue grew 13.0% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 0/2
Debt to equity cannot be calculated: debt is not reported or equity is negative.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 0/1
Debt is not reported.
Interest Coverage 1/1
EBIT is 47.1x against interest expense, well covered.
PE vs Market 0/1
PE (27.5x) is above the market median (11.4x).
PE vs Industry 0/1
PE (27.5x) is above the industry median (22.0x).
PBV 0/1
Price to book (7.3x) is above the industry median (2.9x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 199.6, limit 22.5).
PEG 0/1
PEG needs positive PE and positive 5-year earnings growth.
Dividend Yield 1/2
Dividend yield (3.7%) is above the bottom 25% of dividend payers in the market.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
Payout ratio is 90.5%, above 90% of earnings.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
About ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and s…
Full company profileALPHA financial statements
ALPHA annual financial statements (MYR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 69.0M | 62.1M | 91.1M | 137M | 168M | 177M | 199M |
| Gross Profit | 30.2M | 27.4M | 46.5M | 76.6M | 97.4M | 107M | 119M |
| Operating Income | 4.47M | 14.7M | 31.3M | 55.7M | 72.9M | 70.8M | 69.5M |
| EBITDA | - | - | - | 75.2M | 79.1M | 82.8M | 85.4M |
| Net Income | 2.47M | -3.08M | 14.3M | 53.2M | 52.9M | 57.5M | 53.6M |
| EPS | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Balance Sheet | |||||||
| Total Assets | 75.0M | 92.2M | 107M | 95.9M | 228M | 251M | 255M |
| Total Liabilities | 46.6M | 43.7M | 48.1M | 41.3M | 38.5M | 46.7M | 59.3M |
| Shareholders' Equity | 16.9M | 33.7M | 40.5M | 51.6M | 187M | 198M | 190M |
| Cash & Short-term Investments | 1.76M | 8.23M | 19.3M | 20.0M | 22.9M | 34.4M | 37.0M |
| Cash Flow | |||||||
| Operating Cash Flow | 23.6M | 11.2M | 34.3M | 60.6M | 59.0M | 54.9M | 66.5M |
| Capital Expenditure | 12.0M | 356K | 395K | 866K | 8.41M | 7.81M | 38.1M |
| Free Cash Flow | 11.6M | 10.9M | 33.9M | 59.7M | 50.6M | 47.6M | 28.4M |
| Ratios | |||||||
| ROE | 14.6% | -9.1% | 35.4% | 103.2% | 28.2% | 29.0% | 28.3% |
| ROA | 3.3% | -3.3% | 13.4% | 55.5% | 23.2% | 22.9% | 21.0% |
| Net Profit Margin | 3.6% | -5.0% | 15.7% | 38.7% | 31.6% | 32.5% | 27.0% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
ALPHA dividends
- Dividend yield
- 3.65%
- Forward dividend
- 0.01 MYR
- Payout ratio
- 90.5%
- Ex-dividend date
- Dec 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | MYR 48.5M | 0.01 | 90.5% |
| 2025 | MYR 46.2M | 0.01 | 80.4% |
| 2024 | MYR 31.4M | 0.01 | 59.3% |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns ALPHA
- Insiders 77.62%
- Institutions 14.56%
- Public & others 7.82%
- Shares outstanding 4.83B
- Free float 1.10B
ALPHA company profile
- Company name
- ALPHA
- Ticker
- 0303.KLSE
- ISIN
- MYQ0303OO006
- Exchange
- Kuala Lumpur Exchange
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Employees
- 233
- Fiscal year end
- May
- Address
- Encorp Strand Mall, Petaling Jaya, Malaysia, 47810
- Phone
- 60 3 6141 6166
- Website
- alphaivfgroup.com
About ALPHA
Alpha IVF Group Berhad, together with its subsidiaries, operates as a fertility care specialist that focuses on the provision of assisted reproductive services in Malaysia, Singapore, Indonesia, China, Middle East, the Philippines, and internationally. The company offers assisted reproductive treatment services comprising ovulation induction, intra-uterine insemination, in-vitro fertilization treatment, intra-cytoplasmic sperm injection, gamete intrafallopian transfer, and savior sibling program; preimplantation genetic testing; implantation optimisation; sperm sorting; and egg freezing, embryo freezing and cryo-storage, laparoscopic surgery, hysteroscopic surgery, 4D ultrasound scanning, and artificial intelligence-enhanced embryo selection services. It also provides various diagnostics, testing and screening procedures; cryopreservation of eggs and sperms; medical consultants; fertility, gynecological, and obstetric treatment; and other women-related healthcare and medical services. In addition, the company operates women's specialist centers. Alpha IVF Group Berhad was founded in 2011 and is based in Petaling Jaya, Malaysia.
ALPHA management
7- Dr. Soon Soo Lee MBBSGroup MD, Medical Director of Alpha KL & Non-Independent Executive Director · born 1958
- Dr. Peng Wah NgMedical Director of Genesis & Non-Independent Executive Director · born 1955
- Mr. Hon Lung LiewGroup Chief Financial Officer · born 1986
- Ms. Yun Xin LimGroup Scientific Director · born 1983
- Mr. Kay Pau TanGroup Chief Corporate Officer · born 1989
- Sue Ching LeongCompany Secretary
- Ms. Soon Ai LeeDirector of Operations - Alpha International Women's Specialists (Singapore) Pte. Ltd · born 1953